[
    {
        "pmid": "111111",
        "title": "TP53 missense variants drive colorectal cancer progression",
        "authors": "Smith J; Lee H",
        "journal": "Cancer Res",
        "year": 2022,
        "gene": "TP53",
        "variant": "R175H",
        "disease": "colorectal cancer",
        "study_type": "case-control",
        "n_patients": 120,
        "effect_size": 2.3,
        "abstract": "Mutations such as R175H in TP53 are enriched in colorectal tumors and correlate with poor prognosis and chemoresistance.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/111111/"
    },
    {
        "pmid": "222222",
        "title": "BRCA1 frameshift 185delAG and hereditary breast cancer",
        "authors": "Gonzalez A; Patel R",
        "journal": "Nat Genet",
        "year": 2021,
        "gene": "BRCA1",
        "variant": "185delAG",
        "disease": "breast cancer",
        "study_type": "familial",
        "n_patients": 87,
        "effect_size": 5.1,
        "abstract": "The 185delAG frameshift mutation in BRCA1 disrupts DNA repair, leading to genomic instability and a marked increase in hereditary breast cancer risk.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/222222/"
    },
    {
        "pmid": "333333",
        "title": "EGFR exon 19 deletions predict NSCLC response to TKIs",
        "authors": "Cheng L; Moore D",
        "journal": "J Thorac Oncol",
        "year": 2020,
        "gene": "EGFR",
        "variant": "Exon 19 deletion",
        "disease": "non-small cell lung cancer",
        "study_type": "clinical trial",
        "n_patients": 142,
        "effect_size": 3.7,
        "abstract": "Patients with NSCLC harboring EGFR exon 19 deletions demonstrate prolonged progression-free survival when treated with tyrosine kinase inhibitors like erlotinib.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/333333/"
    },
    {
        "pmid": "444444",
        "title": "KRAS G12D mutation drives pancreatic tumorigenesis",
        "authors": "Nguyen P; Kim Y",
        "journal": "Cell Rep",
        "year": 2019,
        "gene": "KRAS",
        "variant": "G12D",
        "disease": "pancreatic cancer",
        "study_type": "in vivo model",
        "n_patients": 0,
        "effect_size": 4.6,
        "abstract": "Using murine models, KRAS G12D mutations were shown to be sufficient to initiate pancreatic intraepithelial neoplasia and progression to invasive cancer.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/444444/"
    },
    {
        "pmid": "555555",
        "title": "ALK fusion proteins in pediatric anaplastic large cell lymphoma",
        "authors": "Singh R; O’Neill B",
        "journal": "Blood",
        "year": 2018,
        "gene": "ALK",
        "variant": "NPM-ALK",
        "disease": "ALCL",
        "study_type": "observational",
        "n_patients": 63,
        "effect_size": 2.8,
        "abstract": "NPM-ALK fusion proteins drive oncogenesis in pediatric ALCL through constitutive kinase activity and STAT3 pathway activation, highlighting targets for therapy.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/555555/"
    },
    {
        "pmid": "666666",
        "title": "PTEN loss enhances PI3K/AKT signaling in glioblastoma",
        "authors": "Wang Z; Hernandez F",
        "journal": "Neuro Oncol",
        "year": 2021,
        "gene": "PTEN",
        "variant": "loss-of-function",
        "disease": "glioblastoma",
        "study_type": "cell culture",
        "n_patients": 0,
        "effect_size": 3.0,
        "abstract": "PTEN-deficient glioblastoma cells show increased proliferation due to unregulated PI3K/AKT signaling, implicating pathway inhibitors as viable treatments.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/666666/"
    },
    {
        "pmid": "777777",
        "title": "CFTR F508del correction in cystic fibrosis organoids",
        "authors": "Klein A; Desai M",
        "journal": "Sci Transl Med",
        "year": 2022,
        "gene": "CFTR",
        "variant": "F508del",
        "disease": "cystic fibrosis",
        "study_type": "organoid",
        "n_patients": 8,
        "effect_size": 2.9,
        "abstract": "Corrector-potentiator combinations restored chloride conductance in patient-derived organoids with F508del CFTR, supporting ex vivo modeling of therapeutic efficacy.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/777777/"
    },
    {
        "pmid": "888888",
        "title": "APC truncation mutations and WNT activation in colorectal tumors",
        "authors": "Lee H; Gomez T",
        "journal": "Mol Cancer Res",
        "year": 2017,
        "gene": "APC",
        "variant": "truncation",
        "disease": "colorectal cancer",
        "study_type": "tissue analysis",
        "n_patients": 34,
        "effect_size": 1.9,
        "abstract": "Truncated APC proteins fail to degrade β-catenin, resulting in constitutive WNT pathway activation and promotion of tumor growth in colorectal tissue.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/888888/"
    },
    {
        "pmid": "999999",
        "title": "IDH1 R132H mutation alters glioma epigenome",
        "authors": "Zhao M; Kaur D",
        "journal": "Cancer Cell",
        "year": 2016,
        "gene": "IDH1",
        "variant": "R132H",
        "disease": "low-grade glioma",
        "study_type": "epigenomics",
        "n_patients": 47,
        "effect_size": 3.3,
        "abstract": "The R132H mutation in IDH1 produces 2-hydroxyglutarate, causing widespread DNA hypermethylation and altering gene expression profiles in gliomas.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/999999/"
    },
    {
        "pmid": "101010",
        "title": "MLH1 promoter methylation in Lynch syndrome colorectal cancers",
        "authors": "Ahmed S; Tanaka K",
        "journal": "JAMA Oncol",
        "year": 2023,
        "gene": "MLH1",
        "variant": "methylation",
        "disease": "colorectal cancer",
        "study_type": "epigenetics",
        "n_patients": 91,
        "effect_size": 2.1,
        "abstract": "Promoter methylation of MLH1 silences mismatch repair activity in Lynch-associated colorectal cancers, leading to microsatellite instability and higher mutational burden.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/101010/"
    }
]
